Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.03 USD | +10.58% | +11.81% | -10.36% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 329K | Capitalization | 114M |
---|---|---|---|---|---|
Net income 2024 * | -96M | Net income 2025 * | -123M | EV / Sales 2024 * | - |
Net cash position 2024 * | 43.16M | Net cash position 2025 * | 178M | EV / Sales 2025 * | -195 x |
P/E ratio 2024 * |
-1.4
x | P/E ratio 2025 * |
-1.31
x | Employees | 69 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.79% |
Latest transcript on Vigil Neuroscience, Inc.
1 day | +10.58% | ||
1 week | +11.81% | ||
Current month | +16.09% | ||
1 month | -6.77% | ||
3 months | +13.06% | ||
6 months | -55.96% | ||
Current year | -10.36% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 20-06-30 | |
Director of Finance/CFO | 50 | 20-06-30 | |
Kelly Neelon
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 20-06-30 | |
Mary Thistle
BRD | Director/Board Member | 64 | 22-04-17 |
Cheryl Blanchard
BRD | Director/Board Member | 59 | 20-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.67% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 3.03 | +10.58% | 71,507 |
24-05-02 | 2.74 | +3.40% | 49,156 |
24-05-01 | 2.65 | +1.53% | 46,194 |
24-04-30 | 2.61 | +0.38% | 39,199 |
24-04-29 | 2.6 | -4.06% | 68,569 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.36% | 114M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- VIGL Stock